Seeking Editor for Clinical Liver Disease
17 February 2022
17 February 2022
Tommy Ivanics, Carla Fiorella Murillo Perez, Marco P. A. W. Claasen, Madhukar S. Patel, Gabriela Morgenshtern, Lauren Erdman, Chaya Shwaartz, Luckshi Rajendran, Grainne M. O’Kane, Bettina E. Hansen, Sean P Cleary, Gonzalo Sapisochin – 17 February 2022
Mireia Casulleras, Roger Flores‐Costa, Marta Duran‐Güell, Ingrid W. Zhang, Cristina López‐Vicario, Anna Curto, Javier Fernández, Vicente Arroyo, Joan Clària – 17 February 2022 – Albumin infusions are therapeutically used to revert hypoalbuminemia and to replace the extensively oxidized albumin molecule circulating in patients with acutely decompensated (AD) cirrhosis. Because albumin has high affinity for lipids, here we characterized the albumin lipidome in patients with AD and explored the albumin effects on the release of fatty acid (FA)–derived lipid mediators by peripheral leukocytes.
17 February 2022
Li Fan, Qingfei Pan, Wentao Yang, Selene C. Koo, Cheng Tian, Liyuan Li, Meifen Lu, Anthony Brown, Bensheng Ju, John Easton, Sarangarajan Ranganathan, Soona Shin, Alexander Bondoc, Jun J. Yang, Jiyang Yu, Liqin Zhu – 17 February 2022
17 February 2022
Moira B. Hilscher, Michael L. Wells, Sudhakar K. Venkatesh, Frank Cetta, Patrick S. Kamath – 17 February 2022
Jasmin Paris, Neil C. Henderson – 16 February 2022 – The concept of hepatocyte functional zonation is well established, with differences in metabolism and xenobiotic processing determined by multiple factors including oxygen and nutrient levels across the hepatic lobule. However, recent advances in single‐cell genomics technologies, including single‐cell and nuclei RNA sequencing, and the rapidly evolving fields of spatial transcriptomic and proteomic profiling have greatly increased our understanding of liver zonation.
Cumali Efe, Murat Harputluoğlu, Neşe Karadağ Soylu, Sezai Yilmaz – 16 February 2022